Literature DB >> 19935987

Efficacy of biofeedback in the treatment of migraine and tension type headaches.

William J Mullally1, Kathryn Hall, Richard Goldstein.   

Abstract

BACKGROUND: Biofeedback is an established non-pharmacologic technique commonly used in the treatment of migraine and tension type headaches. Multiple published studies have suggested that biofeedback is effective in reducing the frequency and severity of headaches, often allowing patients to decrease their dependence on medication. Studies have also suggested that biofeedback may effect a decrease in medical utilization.
OBJECTIVE: Assess the efficacy of biofeedback in reducing the frequency and severity of migraine and tension type headaches.
DESIGN: Randomized, prospective, single blind, single center controlled trial.
METHODS: Sixty-four patients with migraine with or without aura and/or tension type headaches, by ICHD-1 criteria, age 18 to 55, who had suffered from headaches for more than one year, were entered into the study. Patients were randomly assigned to receive biofeedback in addition to the basic relaxation instruction or relaxation techniques alone. All patients received instruction in pain theory. Biofeedback training consisted of 10 50-minute sessions utilizing standard EMG feedback from the frontalis and trapezius muscles and temperature from the third finger of the dominant hand. Visual and auditory feedback was provided. Thirty-three patients were assigned to receive biofeedback plus the relaxation techniques and 31, the relaxation techniques alone. All patients were asked to respond to periodic questionnaires for 36 months. The primary analysis was an intention-to-treat (ITT) analysis. The subsidiary analyses were not and the 11 subjects (7 in the relaxation alone and 4 in the biofeedback group) who received no treatment at all were analyzed and the results were qualitatively the same.
RESULTS: Patients who completed the program with education in pain theory and relaxation techniques showed a statistically significant decrease in the frequency and severity of the headaches in the first 12 months that continued to 36 months. Biofeedback provided no additional benefit, specifically no change in the frequency or severity of the headaches. After 3 months 48% of those in the relaxation group reported fewer severe headaches, while 35% of those in the biofeedback group reported fewer severe headaches; after 6 months, 52% of those in the relaxation group reported fewer severe headaches as compared with 57% reporting fewer severe headaches in the biofeedback group. The number of medications used by the patients and the utilization of medical care decreased in both groups over 36 months suggesting a regression to the mean. LIMITATIONS: Compliance was an issue throughout the study. Patients dropped out from the outset and that increased over time. Recovery of questionnaires was difficult and fewer were completed at each 3-month interval. Lack of a large control group who did not receive biofeedback or instruction in relaxation techniques.
CONCLUSION: Biofeedback is an extremely costly and time-consuming treatment modality that, in our study, provided no additional benefit when compared to simple relaxation techniques alone, in the treatment of migraine and tension type headaches in adults.

Entities:  

Mesh:

Year:  2009        PMID: 19935987

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  16 in total

Review 1.  [Psychological therapy of migraine: systematic review].

Authors:  G Fritsche; B Kröner-Herwig; P Kropp; U Niederberger; G Haag
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

Review 2.  Psychological Treatments and Psychotherapies in the Neurorehabilitation of Pain: Evidences and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Authors:  Gianluca Castelnuovo; Emanuele M Giusti; Gian Mauro Manzoni; Donatella Saviola; Arianna Gatti; Samantha Gabrielli; Marco Lacerenza; Giada Pietrabissa; Roberto Cattivelli; Chiara A M Spatola; Stefania Corti; Margherita Novelli; Valentina Villa; Andrea Cottini; Carlo Lai; Francesco Pagnini; Lorys Castelli; Mario Tavola; Riccardo Torta; Marco Arreghini; Loredana Zanini; Amelia Brunani; Paolo Capodaglio; Guido E D'Aniello; Federica Scarpina; Andrea Brioschi; Lorenzo Priano; Alessandro Mauro; Giuseppe Riva; Claudia Repetto; Camillo Regalia; Enrico Molinari; Paolo Notaro; Stefano Paolucci; Giorgio Sandrini; Susan G Simpson; Brenda Wiederhold; Stefano Tamburin
Journal:  Front Psychol       Date:  2016-02-19

3.  [Relaxation techniques and behavioural therapy for the treatment of migraine : Guidelines from the German Migraine and Headache Society].

Authors:  P Kropp; B Meyer; T Dresler; G Fritsche; C Gaul; U Niederberger; S Förderreuther; V Malzacher; T P Jürgens; M Marziniak; A Straube
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

Review 4.  Behavioral treatments for migraine management: useful at each step of migraine care.

Authors:  Alexandra B Singer; Dawn C Buse; Elizabeth K Seng
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

Review 5.  Behavioral therapy for chronic migraine.

Authors:  Francesca Pistoia; Simona Sacco; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2013-01

6.  Comparison between efficacy of imipramine and transcutaneous electrical nerve stimulation in the prophylaxis of chronic tension-type headache: a randomized controlled clinical trial.

Authors:  Sayed Ali Mousavi; Sayed Mohssen Mirbod; Fariborz Khorvash
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

7.  Psychological therapies for the prevention of migraine in adults.

Authors:  Louise Sharpe; Joanne Dudeney; Amanda C de C Williams; Michael Nicholas; Ingrid McPhee; Andrew Baillie; Miriam Welgampola; Brian McGuire
Journal:  Cochrane Database Syst Rev       Date:  2019-07-02

8.  Patient outcome in migraine prophylaxis: the role of psychopharmacological agents.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Giulia Serra; Giovanni Dominici; Juliana Fortes-Lindau; Monica Pastina; Ludovica Telesforo; David Lester; Paolo Girardi; Roberto Tatarelli; Paolo Martelletti
Journal:  Patient Relat Outcome Meas       Date:  2010-09-17

9.  Italian guidelines for primary headaches: 2012 revised version.

Authors:  Paola Sarchielli; Franco Granella; Maria Pia Prudenzano; Luigi Alberto Pini; Vincenzo Guidetti; Giorgio Bono; Lorenzo Pinessi; Massimo Alessandri; Fabio Antonaci; Marcello Fanciullacci; Anna Ferrari; Mario Guazzelli; Giuseppe Nappi; Grazia Sances; Giorgio Sandrini; Lidia Savi; Cristina Tassorelli; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2012-05       Impact factor: 7.277

10.  Neurotherapy for chronic headache following traumatic brain injury.

Authors:  David V Nelson; Mary Lee Esty
Journal:  Mil Med Res       Date:  2015-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.